Evidence map›Paper›PMID 41326805›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Trajectories of fatigue-pain-sleep disturbance symptom cluster in patients with lung cancer undergoing chemotherapy and its predictive factors: Latent class growth model.

Dongmei Mao, Yuanyuan Luo, Le Zhang, Suting Liu, Benxiang Zhu, Zhihui Yang, Yang Zhao, Lili Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Identifying the trajectory of SPPADE symptoms in patients with cancer using electronic health record data.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dongmei Mao *School of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Yuanyuan Luo *School of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Le Zhang *School of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Suting LiuSchool of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Benxiang ZhuSchool of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Zhihui YangSchool of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Yang ZhaoSchool of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Lili ZhangSchool of Nursing, Southern Medical University, Guangzhou, 510515, Guangdong, China. zhanglili_gzsmu@163.com.

Funding

National Natural Science Foundation of China 72374097
6 · The paper itself

Abstract

purposeThis study is to investigate the longitudinal trajectories and predictors of the fatigue-pain-sleep disturbance symptom cluster in patients with lung cancer during chemotherapy.

methodsConvenience sampling was used to select 230 patients. Fatigue-pain-sleep disturbance symptom cluster assessments were conducted before the first chemotherapy cycle and on the last day of the first, third, and sixth chemotherapy cycles. Psychological resilience, social support, and clinical blood indices were collected pre-first chemotherapy cycle. The latent class growth model was used to analyze the trajectory of symptom cluster, and multivariate logistic regression analysis was conducted to identify predictors of distinct trajectories.

resultsThe results showed that the fatigue-pain-sleep disturbance symptom cluster included three trajectories: high symptom burden increased group, moderate symptom burden persistent group, and low symptom burden persistent group. The higher the nutritional risk, interleukin-1β (IL-1β), and the lower the self-care ability, social support, albumin-to-globulin ratio (AGR), and lymphocyte-to-monocyte ratio (LMR) were the predictors of the high symptom burden increased group. The higher the IL-1β and the lower the AGR were the predictors of the moderate symptom burden persistent group.

conclusionThe trajectory of the fatigue-pain-sleep disturbance symptom cluster in patients with lung cancer undergoing chemotherapy showed heterogeneity. Regular symptom assessments are essential, and timely, targeted interventions should be implemented for patients with identified risk factors to mitigate the burden of moderate to high level symptoms experienced during chemotherapy cycles.

Indexed as

Antineoplastic AgentsFatigueLung NeoplasmsPainSleep Wake DisordersAdultAgedFemaleHumansInterleukin-1betaLatent Class AnalysisLogistic ModelsLongitudinal StudiesMaleMiddle AgedSocial SupportAntineoplastic AgentsInterleukin-1betaChemotherapyLongitudinal studyLung cancerSymptom cluster

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.